Literature DB >> 35607629

KSNM60: The History of Radiopharmaceutical Sciences in Korea.

Ran Ji Yoo1, Yun-Sang Lee1, Kyo Chul Lee2, Dong Wook Kim3, Dong-Yeon Kim4,5, Yearn Seong Choe6, Jae Min Jeong1.   

Abstract

A number of researchers in Korea have tried to set-up the production of radionuclides and develop new radiopharmaceuticals for several decades. Thanks to their 60-year endeavor to advance the field of radiopharmaceutical sciences, now we have a lot of research units and facilities in Korea. Still, there are huge number of issues to be solved in radiopharmaceutical sciences; however, our efforts will be continued to develop new radiopharmaceuticals and to apply the new radiopharmaceuticals into nuclear medicine field.
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2022.

Entities:  

Keywords:  Cyclotron; Radiochemistry; Radioisotopes; Radiopharmaceutical sciences

Year:  2022        PMID: 35607629      PMCID: PMC9123153          DOI: 10.1007/s13139-022-00744-8

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  91 in total

1.  Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.

Authors:  Yun-Sang Lee; Jae Min Jeong; Young Joo Kim; Young Soo Chang; Hak Jeong Lee; Miwon Son; Jung Woo Lee; Heung Sik Yoon; Won Jun Kang; Dong Soo Lee; June-Key Chung; Myung Chul Lee; Young-Ger Suh
Journal:  Appl Radiat Isot       Date:  2006-09-28       Impact factor: 1.513

2.  Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.

Authors:  Iljung Lee; Jehoon Yang; Jung Hee Lee; Yearn Seong Choe
Journal:  Bioorg Med Chem Lett       Date:  2011-08-10       Impact factor: 2.823

3.  Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase.

Authors:  Eun Kyoung Ryu; Yearn Seong Choe; Eun Young Park; Jin-Young Paik; Yu Ri Kim; Kyung-Han Lee; Yong Choi; Sang Eun Kim; Byung-Tae Kim
Journal:  Nucl Med Biol       Date:  2005-02       Impact factor: 2.408

4.  Radiosynthesis and evaluation of 18F-labeled aliphatic phosphonium cations as a myocardial imaging agent for positron emission tomography.

Authors:  Dong-Yeon Kim; Hyeon Sik Kim; Jung-Joon Min
Journal:  Nucl Med Commun       Date:  2015-07       Impact factor: 1.690

5.  Synthesis of [¹⁸F]-labeled (2-(2-fluoroethoxy)ethyl)triphenylphosphonium cation as a potential agent for myocardial imaging using positron emission tomography.

Authors:  Dong-Yeon Kim; Hee-Jung Kim; Kook-Hyun Yu; Jung-Joon Min
Journal:  Bioorg Med Chem Lett       Date:  2011-11-10       Impact factor: 2.823

6.  Angiogenesis imaging in myocardial infarction using 68Ga-NOTA-RGD PET: characterization and application to therapeutic efficacy monitoring in rats.

Authors:  Jae Seon Eo; Jin Chul Paeng; Song Lee; Yun-Sang Lee; Jae Min Jeong; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Coron Artery Dis       Date:  2013-06       Impact factor: 1.439

7.  Novel one-pot one-step synthesis of 2'-[(18)F]fluoroflumazenil (FFMZ) for benzodiazepine receptor imaging.

Authors:  Young Hyun Yoon; Jae Min Jeong; Hyung Woo Kim; Sung Hyun Hong; Yun-Sang Lee; Hee Sup Kil; Dae Yoon Chi; Dong Soo Lee; June-Key Chung; Myung Chul Lee
Journal:  Nucl Med Biol       Date:  2003-07       Impact factor: 2.408

8.  A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water.

Authors:  Dong Wook Kim; Yearn Seong Choe; Dae Yoon Chi
Journal:  Nucl Med Biol       Date:  2003-05       Impact factor: 2.408

9.  188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis.

Authors:  E B Lee; K C Shin; Y J Lee; Y J Lee; G J Cheon; J M Jeong; M W Son; Y W Song
Journal:  Nucl Med Commun       Date:  2003-06       Impact factor: 1.690

10.  Synthesis and evaluation of radioiodine-labelled CP-118,954 for the in-vivo imaging of acetylcholinesterase.

Authors:  Iljung Lee; Yearn Seong Choe; Eun Kyoung Ryu; Byoung Wook Choi; Joon Young Choi; Yong Choi; Kyung-Han Lee; Byung-Tae Kim
Journal:  Nucl Med Commun       Date:  2007-07       Impact factor: 1.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.